Full Press Release Details
Ultragenyx and Kyowa Hakko Kirin Announce Submission of Burosumab's Biologics License Application in the US.
RARE
Ultragenyx and Kyowa Hakko Kirin Announce Submission of Burosumab's Biologics License Application in the US
Key Takeaway: Ultragenyx and Kyowa Hakko Kirin Announce Submission of Burosumab's Biologics License Application in the US